Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Hepatology, Medicine and Policy|October 6, 2018
Innovative sources for funding of viral hepatitis prevention and treatment in low- and middle-income countries: a roundtable meeting reportDavid FitzSimons, Greet Hendrickx, Johannes Hallauer, et al.Hepatology, Medicine and Policy|October 6, 2018
Incidence of hepatitis C among people who inject drugs in IrelandAnne Marie Carew, Niamh Murphy, Jean Long, et al.Hepatology, Medicine and Policy|October 6, 2018
Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and accessTongai G Maponga, Rachel Matteau Matsha, Sébastien Morin, et al.Hepatology, Medicine and Policy|October 6, 2018
Design of the Prospective Real-world Outcomes Study of hepatic encephalopathy Patients' Experience on Rifaximin-α (PROSPER): an observational study among 550 patientsAleksander Krag, Marcus Schuchmann, Hanna Sodatonou, et al.Hepatology, Medicine and Policy|October 6, 2018
Drug consumption rooms (DCRs) as a setting to address hepatitis C - findings from an international online surveyVendula Belackova, Allison M Salmon, Eberhard Schatz, et al.Hepatology, Medicine and Policy|February 21, 2017
Insights on the Russian HCV Care Cascade: Minimal HCV Treatment for HIV/HCV Co-infected PWID in St. PetersburgJudith I Tsui, Stephen C Ko, Evgeny Krupitsky, et al.Hepatology, Medicine and Policy|October 6, 2018
Predisposing, enabling, and need factors associated with utilization of HCV testing services among PWID in two settings in IndiaRuchi Sogarwal, Varada Madge, Pratyush Bishi, et al.Hepatology, Medicine and Policy|October 6, 2018
Hepatitis B knowledge among women of childbearing age in three slums in Mumbai: a cross-sectional surveySwati Jha, Divyesh Devaliya, Susan Bergson, et al.Hepatology, Medicine and Policy|October 6, 2018
Coverage of different health insurance programs and medical costs associated with chronic hepatitis C infection in mainland China: a cross-sectional survey in 20 provincesHai-Yang Zhou, Shuang Liu, Su-Jun Zheng, et al.Hepatology, Medicine and Policy|October 6, 2018
Antiretroviral therapy and liver disease progression in HIV and hepatitis C co-infected patients: a systematic review and meta-analysisAlexis Llewellyn, Mark Simmonds, Will L Irving, et al.Pageof 4